Physiology and pharmacology of two-pore domain potassium channels

Current Pharmaceutical Design

Volumn 11, Issue 21, 2005, Pages 2717-2736

  Kim, Donghee ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Anesthetic agent; Background potassium channel; Free fatty acids; G protein coupled receptor; Mechanosensitivity; pH; Two pore domain potassium channel

Indexed keywords

BUPIVACAINE; CLOFILIUM; DESFLURANE; G PROTEIN COUPLED RECEPTOR; GLIBENCLAMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOTHANE; INWARDLY RECTIFYING POTASSIUM CHANNEL; ISOFLURANE; LIDOCAINE; MESSENGER RNA; NEUROTRANSMITTER; POTASSIUM ION; PROPAFENONE; PROTEIN 14 3 3; QUINIDINE; SMALL INTERFERING RNA; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

AMINO ACID SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE POTENTIAL; CELL PH; CELL TYPE; CONCENTRATION (PARAMETERS); DRUG MECHANISM; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; MOLECULAR CLONING; NONHUMAN; PHYLOGENY; POTASSIUM CELL LEVEL; POTASSIUM CURRENT; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BLOCKING; REVIEW; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 22944473967     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612054546824     Document Type: Review

References (163)

1. Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C, et al. Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J 1996; 15: 6854-62.
2. Lesage F, Lauritzen I, Duprat F, Reyes R, Fink M, Heurteaux C, et al. The structure, function and distribution of the mouse TWIK-1 K+ channel. FEBS Lett 1997; 402: 28-32.
3. Nicolas MT, Barhanin J, Reyes R, Dememes D. Cellular localization of TWIK-1, a two-pore-domain potassium channel in the rodent inner car. Hear Res 2003; 181: 20-6.
4. Medhurst AD, Rennie G, Chapman CG, Meadows H, Duckworth MD, Kelsell RE, et al. Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery. Brain Res Mol Brain Res 2000; 86: 101-14.
5. Duprat F, Lesage F, Fink M, Reyes R. Heurteaux C, Lazdunski M. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J 1997; 16: 5464-71.
6. Kim Y, Bang H, Kim D. TASK-3, a new member of the tandem pore K(+) channel family. J Biol Chem 2000; 275: 9340-7.
7. Rajan S, Wischmeyer E, Xin Liu G, Preisig-Muller R, Daut J, Karschin A, et al. TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An extracellular histiding as pH sensor. J Biol Chem 2000; 275: 16650-7.
8. Kim Y, Bang H, Kim D. TBAK-1 and TASK-1, two-pore K(+) channel subunits: kinetic properties and expression in rat heart. Am J Physiol 1999; 277: H1669-78.
9. Talley EM, Solorzano G, Lei Q, Kim D, Bayiiss DA. Cns distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 2001; 21: 7491-505.
10. Karschin C, Wischmeyer E, Preisig-Muller R, Rajan S, Derst C, Grzeschik KH, et al. Expression pattern in brain of TASK-1, TASK-3, and a tandem pore domain K(+) channel subunit, TASK-5, associated with the central auditory nervous systems. Mol Cell Neurosci 2001; 18: 632-78.
11. Chapman CG, Meadows HJ, Godden RJ, Campbell DA, Duckworth M, Kelsell RE, et al. Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channel. Brain Res Mol Brain Res 2000; 82: 74-83.
12. Meadows HJ, Randall AD. Functional characterisation of human TASK-3, and acid-sensitive two-pore domain potassium channel. Neuropharmacology 2001; 40: 551-9.
13. Lopes CM, Zilberberg N, Goldstein SA. Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers. J Biol Chem 2001; 276: 24449-52.
14. Morton MJ, O'Connell AD, Sivaprasadarao A, Hunter M. Determinants of pH sensing in the two-pore domain K(+) channel TASK-1 and -2. Pflugers Arch 2003; 445: 577-83.
15. Yuill K, Ashmole I, Stanfield PR. The selectivity filter of the tandem pore potassium channel TASK-1 and its pH-sensitivity and ionic selectivity. Pflugers Arch 2003; 4448: 63-69.
16. Bayliss DA, Talley EM, Sirois JE, Lei Q. TASK-1 is a highly modulated pH-sensitive 'leak' K(+) channel expressed in brainstem respiratory neurons. Respir Physiol 2001; 129: 159-74.
17. Palmer MJ, Hull C, Vigh J, Von Gersdorff H. Synaptic cleft acidification and modulation of short-term depression by exocytosed protons in retinal bipolar cells. J Neurosci 2003; 23: 11332-41.
18. Han J, Truell J, Gnatenco C, Kim D. Characterization of four types of background potassium channels in rat cerebellar granule neurons. J Physiol 2002; 542: 431-44.
19. Leonoudakis D, Gray AT, Winegar BD, Kindler CH, Harada M, Taylor DM, et al. An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum. J Neurosci 1998; 18: 868-77
20. Hajdu P, Ulens C, Panyi G, Tytgat J. Drug- and mutagenesis-induced changes in the selectivity filter of a cardiac two-pore background K+ channel. Cardiovasc Res 2003; 58: 46-54.
21. Czirjak G, Enyedi P. Ruthenium red inhibits TASK-3 potassium channel by interconnecting glutamate 70 of the two subunits. Mol Pharmacol 2003; 63: 646-52.
22. Patel AJ, Honore E, Lesage F, Fink M, Romey G, Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 1999; 2: 422-6.
23. Sirois JE, Lei Q, Talley EM, Lynch C, 3rd. Bayliss DA. The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. J Neurosci 2000; 20: 6347-54.
24. Talley EM, Bayliss DA. Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action. J Biol Chem 2002; 277: 17733-42.
25. Maingret F, Patel AJ, Lazdunski M, Honore E. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. EMBO J 2001; 20: 47-54.
26. Barbuti A, Ishii S, Shimizu T, Robinson RB, Feinmark SJ. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am J Physiol Heart Circ Physiol 2002; 282: H2024-30.
27. Czirjak G, Enyedi P. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem 2002; 277: 5426-32.
28. Czirjak G, Enyedi P. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol 2002; 16: 621-9.
29. Fearon IM, Zhang M, Vollmer C, Nurse CA. GABA mediates autoreceptor feedback inhibition in the rat carotid body via presynaptic GABAB receptors and TASK-1. J Physiol 2003; 553: 83-94.
30. Perrier JF, Alaburda A, Hounsgaard J. 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle. J Physiol 2003; 548: 485-92.
31. Czirjak G, Petheo GL, Spat A, Enyedi P. Inhibition of TASK-1 potassium channel by phospholipase C. Am J Physiol Cell Physiol 2001; 281: C700-8.
32. Chemin J, Girard C, Duprat F, Lesage F, Romey G, Lazdunski M. Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels. EMBO J 2003; 22: 5403-11.
33. Boyd DF, Millar JA, Watkins CS, Mathie A. The role of Ca2+-stores in the muscarinic inhibition of the K+ current IK(SO) in neonatal rat cerebellar granule cells. J Physiol 2000; 529 Pt 2: 321-31.
34. Huang CL, Feng S, Hilgemann DW. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature 1998; 391: 803-6.
35. Sirois JE, Lynch C, 3rd, Bayliss DA. Convergent and reciprocal modulation of a leak K+ current and I(h) by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones. J Physiol 2002; 541: 717-29.
36. O'Kelly I, Stephens RH, Peers C, Kemp PJ. Potential identification of the O2-sensitive K+ current in a human neuroepithelial body-derived cell linc. Am J Physiol 1999; 276: L96-L104.
37. Buckler KJ, Williams BA, Honore E. An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol 2000; 525 Pt 1: 135-42.
38. Lewis A, Hartness ME, Chapman CG, Fearon IM, Meadows HJ. Peers C et al. Recombinant hTASK1 is an O(2)-sensitive K(+) channel. Biochem Biophys Res Commun 2001; 285: 1290-4.
39. Williams BA, Bucker KJ. Biophysical properties and metabolic regulation of a TASK-like potassiumn channel in rat carotid body type-1 cells. Am J Physiol Lung Cell Mol Physiol 2003.
40. Johnson RP, O'Kelly IM, Fearon IM. System-specific O2-sensitivity of the tandem-pore-domain K+ channel TASK-1. Am J Physiol Cell Physiol 2003.
41. Hartness ME, Lewis A, Searle GJ, O'Kelly I, Peers C, Kemp PJ. Combined antisense and pharmacological approaches implicate hTASK as an airway O(2) sensing K(+) channel. J Biol Chem 2001; 276: 26499-508.
42. Plant LD, Kemp PJ, Peers C, Henderson Z, Pearson HA. Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. Stroke 2002; 33: 2324-8.
43. Lauritzen I, Zanzouri M, Honore E, Duprat F, Ehrengruber MU, Lazdunski M, et al. K+-dependent cerebellar granule neuron apoptosis: Role of TASK leak K+ channels. J Biol Chem 2003.
44. Kang D, Han J, Talley EM, Bayliss DA, Kim D. Functional Expression of TASK-1/TASK-3 Heteromers in Cerebellar Granule Cells. J Physiol 2003.
45. Han J, Gnatenco C, Sladek CD, Kim D. Background and tandem-pore potassium channels in magnocellular neurosecretory cells of the rat supraoptic nucleus. J Physiol 2003; 546: 625-39.
46. Watkins CS, Mathie A. A non-inactivating K+ current sensitive to muscarinic receptor activation in rat cultured cerebellar granule neurons. J Physiol 1996; 491: 401-12.
47. Rajan S, Preisig-Muller R, Wischmeyer E, Nehring R, Hanley PJ, Renigunta V, et al. Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3. J Physiol 2002; 545: 13-26.
48. O'Kelly I, Butler MH, Zilberberg N, Goldstein SA. Forward transport 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 2002; 111: 577-88.
49. Girard C, Tinel N, Terrenoire C, Romey G, Lazdunski M, Borsotto M. p11, an annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1. EMBO J 2002; 21: 4439-48.
50. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev 2002; 82: 331-71.
51. Jones SA, Morton MJ, Hunter M, Boyett MR. Expression of TASK-1, a pH-sensitive twin-pore domain K(+) channel, in rat myocytes. Am J Physiol Heart Circ Physiol 2002; 283: H181-5.
52. Lopes CM, Gallagher PG, Buck ME, Butler MH, Goldstein SA. Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3. J Biol Chem 2000; 275: 16969-78.
53. Millar AJ, Barrat L, Southan AP, Page KM, Fyffe REW, Robertson B, et al. A Functional Role for the Two-pore Domain Potassium Channel TASK-1 in Cerebellar Granule Neurons. Proc. Natl. Acad. Sci. 2000; 97: 3614-3618.
54. Meuth SG, Budde T, Kanyshkova T, Broicher T, Munsch T, Pape HC. Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons. J Neurosci 2003; 23: 6460-9.
55. Talley EM, Lei Q, Sirois JE, Bayliss DA. TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons. Neuron 2000; 25: 399-410.
56. Washburn CP, Sirois JE, Talley EM, Guyenet PG, Bayliss DA. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. J Neurosci 2002; 22: 1256-65.
57. Bortner CD, Hughes FM Jr, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem 1997; 272: 32436-42.
58. Yu SP. Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol 2003; 70: 363-86.
59. D'Mello SR, Galli C, Ciotti T, Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 1993; 90: 10989-93.
60. Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 1995; 15: 1172-9.
61. Schulz JB, Weller M, Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci 1996; 16: 4696-706.
62. Trimarchi JR, Liu L, Smith PJ, Keefe DL. Apoptosis recruits two-pore domain potassium channels used for homeostatic volume regulation. Am J Physiol Cell Physiol 2002; 282: C588-94.
63. Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 2003; 23: 4798-802.
64. Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 2003; 3: 297-302.
65. Pei L, Wiser O, Slavin A, Mu D, Powers S, Jan LY, Hoey T. Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci USA 2003; 100: 7803-7.
66. Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S, et al. Oncogenic potential of EAG K(+) channels. EMBO J 1999; 18: 5540-7.
67. Huang Y, Rane SG. Potassium channel induction by the Ras/Raf signal transduction cascade. J Biol Chem 1994; 269: 31183-9.
68. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE. Two-Pore Domain K Channel, TASK-1, in Pulmonary Artery Smooth Muscle Cells. Circ Res 2003.
69. Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 2001; 409: 88-92.
70. Kim D, Gnatenco C. TASK-5, a new member of the tandem-pore K(+) channel family. Biochem Biophys Res Commun 2001; 284: 923-30.
71. Ashmole I, Goodwin PA, Stanfield PR. TASK-5, a novel member of the tandem pore K+ channel family. Pflugers Arch 2001; 442: 828-33.
72. Meadows HJ, Benham CD, Cairns W, Glower I, Jennings C, Medhurst AD, et al. Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel. Pflugers Arch 2000; 439: 714-22.
73. Bang H, Kim Y, Kim D. TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family. Journal of Biological Chemistry 2000; 275: 17412-9.
74. Lesage F, Terrenoire C, Romey G, Lazdunski M. Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem 2000; 275: 28398-405.
75. Hervieu GJ, Cluderay JE, Gray CW, Green PJ, Ranson JL, Randall AD, et al. Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 2001; 103: 899-919.
76. Gu W, Schlichthörl G, Hirsch JR, Engels H, Karschin C, Karschin A, et al. Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J. Physiol. 2002; 539: 657-668.
77. Maingret F, Honore E, Lazdunski M, Patel AJ. Molecular basis of the voltage-dependent gating of TREK-1, a mechano-sensitive K(+) channel. Biochem Biophys Res Commun 2002; 292: 339-46.
78. Nicoll RA, Madison DV. General anesthetics hyperpolarize neurons in the vertebrate central nervous system. Science 1982; 217: 1055-7.
79. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607-14.
80. Mihic SJ, Ye Q, Wick MJ, Koltchine VV. Krasowski MD, Finn SE, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-9.
81. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65: 443-52.
82. Punke MA, Licher T, Pongs O, Friederich P. Inhibition of Human TREK-1 Channels by Bupivacaine. Anesth Analg 2003; 96: 1665-73.
83. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 1999; 274: 26691-6.
84. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore L. Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. J Biol Chem 2000; 275: 10128-33.
85. Maingret F, Lauritzen I, Patel AJ, Heurteaux C, Reyes R, Lesage F, et al. TREK-1 is a heat-activated background K(+) channel. EMBO J 2000; 19: 2483-91.
86. Maingret F, Fosset M, Lesage F, Lazdunski M, Honore E. TRAAK is a mammalian neuronal mechano-gated K+ channel. J Biol Chem 1999; 274: 1381-7.
87. Patel AJ, Honore E, Maingret F, Lesage F, Fink M, Duprat F, et al. A mammalian two pore domain mechano-gated S-like K+ channel. EMBO J 1998; 17: 4283-90.
88. Kim Y, Gnatenco C, Bang H, Kim D. Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch 2001; 442: 952-60.
89. Patel AJ, Lazdunski M, Honore E. Lipid and mechano-gated 2P domain K(+) channels. Curr Opin Cell Biol 2001; 13: 422-8.
90. Honore E, Maingret F, Lazdunski M, Patel AJ. An intracellular proton sensor commands lipid- and mechano-gating of the K(+) channel TREK-1. EMBO J 2002; 21: 2968-76.
91. Miller P, Kemp PJ, Lewis A, Chapman CG, Meadows HJ, Peers C. Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection. J Physiol 2003; 548: 31-7.
92. Miller P, Peers C, Kemp PJ. Polymodal regulation of hTREK1 by pH, arachidonic acid and hypoxia: physiological impact in acidosis and alkalosis. Am J Physiol Cell Physiol 2003; 286: C272-282.
93. Terrenoire C, Lauritzen I, Lesage F, Romey G, Lazdunski M. A TREK-1-like potassium, channel in aerial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics. Circ Res 2001; 89: 336-42.
94. Koh SD, Monaghan K, Sergeant GP, Ro S, Walker RL, Sanders KM, et al. TREK-1 Regulation by Nitric Oxide and cGMP-dependent Protein Kinase. An essential role in smooth MUSCLE inhibitory neurotransmission. J Biol Chem 2001; 276: 44338-46.
95. Aimond F, Rauzier JM, Bony C, Vassort G. Simultaneous activation of p38 MAPK and p42/44 MAPK by ATP stimulates the K+ current ITREK in cardiomyocytes. J Biol Chem 2000; 275: 39110-6.
96. Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M, et al. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 1998; 17: 3297-308.
97. Kim Y, Bang H, Gnatenco C, Kim D. Synergistic interaction and the role of C-terminus in the activation of TRAAK K+ channels by pressure, free fatty acids and alkali. Pflugers Arch 2001; 442: 64-72.
98. Yamamoto Y, Taniguchi K. Heterogeneous expression of TASK-3 and TRAAK in rat paraganglionic cells. Histochem Cell Biol 2003; 120: 335-9.
99. Yamamoto Y, Kummer W, Atoji Y, Suzuki Y. TASK-1, TASK-2, TASK-3 and TRAAK immunoreactivities in the rat carotid body. Brain Res 2002; 950: 304-7.
100. Ozaita A, Vega-Saenz de Miera E. Cloning of two transcripts, HKT4.1a and HKT4.1b, from the human two-pore K+ channel gene KCNK4. Chromosomal localization, tissue distribution and functional expression. Brain Res Mol Brain Res 2002; 102: 18-27.
101. Belardetti F, Kandel ER, Siegelbaum SA. Neuronal inhibition by the peptide FMRFamide involves opening of S K+ channels. Nature 1987; 325: 153-6.
102. Vandorpe DH, Small DL, Dabrowski AR, Morris CE. FMRFamide and membrane stretch as activators of the Aplysia S-channel. Biophys J 1994; 66: 46-58.
103. Kim D, Clapham DE. Potassium channels in cardiac cells activated by arachidonic acid and phospholipids. Science 1989; 244: 1174-6.
104. Kim D. A mechanosensitive K channel in heart cells: activation by arachidonic acid. J Gen Physiol 1992; 100: 1-20.
105. Niu W, Sachs F. Dynamic properties of stretch-activaed K+ channels in adult rat atrial myocytes. Prog Biophys Mol Biol 2003; 82: 121-35.
106. Ordway RW, Walsh JV Jr, Singer JJ. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science 1989; 244: 1176-9.
107. Devor DC, Frizzell RA. Modulation of K+ channels by arachidonic acid in T84 cells. II. Activation of a Ca(2+)-independent K+ channel. Am J Physiol 1998; 274: C149-60.
108. Enyeart JJ, Xu L, Danthi S, Enyeart JA. An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1. J Biol Chem 2002; 277: 49186-99.
109. Enyeart JA, Danthi S, Enyeart JJ. Corticotropin induces the expression of TREK-3 mRNA and K+ current in adrenocortical cells. Mol Pharmacol 2003; 64: 132-42.
110. Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M. The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 2000; 57: 906-12.
111. Meadows HJ, Chapman CG, Duckworth DM, Kelsell RE, Murdock PR, Nasir S, et al. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. Brain Res 2001; 892: 94-101.
112. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski I. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784-93
113. Xu X, Pan Y, Wang, X. Alterations in the expression of lipid and mechano-gated two-pore domain potassium channel genes in rat brain following chronic cerebral ischemia. Brain Res Mol Brain Res 2004; 120: 205-9.
114. Gnatenco C, Han J, Snyder AK, Kim D. Functional expression of TREK-2 K+ channel in cultured rat brain astrocytes. Brain Res 2002; 931: 56-67.
115. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, et al. TREK-1, a K(+) channel involved in neuroprotection and general anesthesia. EMBO J 2004 (April): 1-15 (published on line).
116. Reyes R, Duprat F, Lesage F, Fink M, Salinas M, Farman N, et al. Cloning and expression of a novel pH-sensitive two pore domain K+ channel from human kidney. J Biol Chem 1998; 273: 30863-9.
117. Girard C, Duprat F, Terrenoire C, Tinel N, Fosset M, Romey G. et al. Genomic and functional characteristics of novel human pancreatic 2P domain K(+) channels. Biochem Biophys Res Commun 2001; 232: 249-56.
118. Decher N, Maier M, Dittrich W, Gassenhuber J, Bruggemann A, Busch AE, et al. Characterization of TASK-4, a novel member of the pH-sensitive, two-pore domain potassium channel family. FEBS Lett 2001; 192: 84-9.
119. Han J, Kang D, Kim D. Functional Properties of Four Splice Variants of a Human Pancreatic Tandem-Pore K+ channel, TALK-1. Am J Physiol Cell Physiol 2003; 285: C529-538.
120. Gray AT, Zhao BB, Kindler CH, Winegar BD, Mazurek MJ, Xu J, et al. Volatile anesthetics activate the human tandem pore domain baseline K+ channel KCNK5. Anesthesiology 2000; 92: 1722-30.
121. Levy DI, Velazquez H, Goldstein SA, Bockenhauer D. Segment-specific expression of 2P domain potassium channel genes in human nephron. Kidney Int 2004; 65: 918-26.
122. Gabriel A, Abdallah M, Yost CS, Winegar BD, Kindler CH. Localization of the tandem pore domain K+ channel KCNK5 (TASK-2) in the rat central nervous system. Brain Res Mol Brain Res 2002; 98: 153-63.
123. Niemeyer MI, Cid LP, Barros LF, Sepulveda FV. Modulation of the two-pore domain acid-sensitive K+ channel TASK-2 (KCNK5) by changes in cel volume. J Biol Chem 2001; 276: 43166-74.
124. Barriere H, Belfodil R, Rubera I, Tauc M, Lesage F, Poujeol C, et al. Role of TASK2 Potassium Channels Regarding Volume Regulation in Primary Cultures of Mouse Proximal Tubules. J Gen Physiol 2003; 122: 177-190.
125. Kang DW, Kim D. Single-channel properties and pH sensitivity of two-pore domain K+ channels of the TALK family. Biochem Biophys Res Commun 2004; 315: 836-844.
126. Kindler CH, Paul M, Zou H, Liu C, Winegar BD, Gray AT, Yost CS. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5). J Pharmacol Exp Ther 2003; 306: 84-92.
127. Kindler CH, Yest CS, Gray AT. Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem. Anesthesiology 1999; 90: 1092-102.
128. Yost CS. Tandem pore domain K channels: an important site of volatile anesthetic action? Curr Drug Targets 2000; 1: 207-17.
129. Gerstin KM, Gong DH, Abdallah M, Winegar BD, Eger EI, 2nd. Gray AT. Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar anesthetic concentration. Anesth Analg 2003; 96: 1345-9, table of contents.
130. Rajan S, Wischmeyer E, Karschin C, Preisig-Muller R, Grzeschik KH, Daut J, et al. THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+ channels. J Biol Chem 2001; 276: 7302-11.
131. Bushell T, Clarke C, Mathie A, Robertson B. Pharmacological characterization of a non-inactivating outward current observed in mouse cerebellar Purkinje neurones. Br J Pharmacol 2002; 135: 705-12.
132. Sano Y, Inamura K, Miyake A, Mochizuki S, Kitada C, Yokoi H, et al. A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord. J Biol Chem 2003.
133. Salinas M, Reyes R, Lesage F, Fosset M, Heurteaux C, Romey G, et al. Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure. J Biol Chem 1999; 274: 11751-60.
134. Bockenhauer D, Nimmakayalu MA, Ward DC, Goldstein SA, Gallagher PG. Genomic organization and chromosomal localization of the murine 2 P domain potassium channel gene Kcnk8: conservation of gene structure in 2 P domain potassium channels. Gene 2000; 261: 365-72.
135. Ketchum KA, Joiner WJ, Sellers AJ, Kaczmarek LK, Goldstein SA. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature 1995; 376: 690-5.
136. Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G, et al. A pH-sensitive yeast outward rectifier K+ channel with two pore domains and novel gating properties. J Biol Chem 1996; 271: 4183-7.
137. Reid JD, Lukas W, Shafaatian R, Bertl A, Scheurmann-Kettner C, Guy HR, et al. The S. cerevisiae outwardly-rectifying potassium channel (DUK1) identifies a new family of channels with duplicated pore domains. Receptors Channels 1996; 4: 51-62.
138. Czempinski K, Zimmermann S, Ehrhardt T, Muller-Rober B. New structure and function in plant K+ channels: KCO1, an outward rectifier with a steep Ca2+ dependency. EMBO J 1997; 16: 2565-75.
139. Gray AT, Winegar BD, Leonoudakis DJ, Forsayeth JR, Yost CS. TOK1 is a volatile anesthetic stimulated K+ channel. Anesthesiology 1998; 88: 1076-84.
140. Ahmed A, Sesti F, Ilan N, Shih TM, Sturley SL, Goldstein SA. A molecular target for viral killer toxin: TOK1 potassium channels. Cell 1999; 99: 283-91.
141. Sesti F, Shih TM, Nikolaeva N, Goldstein SA. Immunity to K1 killer toxin: internal TOK1 blockade. Cell 2001; 105: 637-44.
142. Goldstein SN, Price LA, Rosenthal DN, Pausch MH. ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc Nat Acad Sci USA 1996; 93: 13256-13261.
143. Zilberberg N, Ilan N, Gonzalez-Colaso R, Goldstein SA. Opening and closing of KCNKO potassium leak channels is tightly regulated. J Gen Physiol 2000; 116: 721-34.
144. Wei A, Jegla T, Salkoff L. Fight potassium channel families revealed by the C. elegans Genome project. Neuropharmacology 1996; 35: 805-829.
145. Kunkel MT, Johnstone DB, Thomas JH, Salkoff L. Mutants of a temperature-sensitive two-P domain potassium channel. J Neurosci 2000; 20: 7517-24.
146. de la Cruz IP, Levin JZ, Cummins C, Anderson P, Horvitz HR. sup-9, sup-10, and unc-93 may encode components of a two-pore K+ channel that coordinates muscle contraction in Caenorhabditis elegans. J Neurosci 2003; 23: 9133-45.
147. Vergani P, Blatt MR. Mutations in the yeast two pore K+ channel YKC1 identify functional differences between the pore domains. FEBS Lett 1999; 458: 285-91.
148. Fairman C, Zhou X, Kung C. Potassium uptake through the TOK1 K+ channel in the budding yeast. J Membr Biol 1999; 168: 149-57.
149. Loukin SH, Valliant B, Zhou XL, Spalding EP, Kung C, Saimi Y. Random mutagenesis reveals a region important for gating of the yeast K+ channel Ykc1. EMBO J 1997; 16: 4817-25.
150. Saldana C, Naranjo D, Coria R, Pena A, Vaca L. Splitting the two pore domains from TOK1 results in two cationic channels with novel functional properties. J Biol Chem 2002; 277: 4797-805.
151. Zilberberg N, Ilan N, Goldstein SA. KCNKO: opening and closing the 2-P-domain potassium leak channel entails "C-type" gating of the outer pore. Neuron 2001; 32: 635-48.
152. Chapman ML, Krovetz HS, VanDongen AM. GYGD pore motifs in neighbouring potassium channel subunits interact to determine ion selectivity. J Physiol 2001; 530: 21-33.
153. Goldstein SAN, Wang K-W, Ilan N, Pausch MH. Sequence and function of the two P domain potassium channels: implications of an emerging superfamily. J Mol Med 1998; 76: 13-20.
154. Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol 2000; 279: F793-801.
155. Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N. Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2001; 2: 175-84.
156. Patel AJ, Honore E. Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci 2001; 24: 339-46.
157. O'Connell AD, Morton MJ, Hunter M. Two-pore domain K+ channels-molecular sensors. Biochim Biophys Acta 2002; 1566: 152-61.
158. Talley EM, Sirois JE, Lei Q, Bayliss DA. Two-pore-Domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist 2003; 9: 46-56.
159. Lesage F. Pharmacology of neuronal background potassium channels. Neuropharmacology 2003; 44: 1-7.
160. Kim D. Fatty acid-sensitive two-pore domain K(+) channels. Trends Pharmacol Sci 2003; 24: 648-54.
161. Horvath TL, Castaneda T, Tang-Christensen M, Pagotto U, Tschop MH. Ghrelin as a potential anti-obesity target. Curr Pharm Design 2003; 9(17): 1383-95.
162. Huang X, Liu H, Cui M, Fu W, Yu K, Chen K, et al. Simulating the interactions of toxins with K+ channels. Curr Pharm Design 2004; 10(9): 1057-67.
163. Wassermann GF, Loss ES. Testosterone action on the Sertoli cell membrane: a KIR6.x channel related effect. Curr Pharm Design 2004; 10(21): 2649-56.